4-IBP

CAS No. 155798-08-6

4-IBP( —— )

Catalog No. M18082 CAS No. 155798-08-6

4-IBP is a selective σ1 agonist with a high level of affinity for the σ1 receptor (Ki = 1.7 nM) and a moderate affinity for the σ2 receptor (Ki = 25.2 nM) .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 30 In Stock
25MG 64 In Stock
50MG 110 In Stock
100MG 161 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-IBP
  • Note
    Research use only, not for human use.
  • Brief Description
    4-IBP is a selective σ1 agonist with a high level of affinity for the σ1 receptor (Ki = 1.7 nM) and a moderate affinity for the σ2 receptor (Ki = 25.2 nM) .
  • Description
    4-IBP is a selective σ1 agonist with a high level of affinity for the σ1 receptor (Ki = 1.7 nM) and a moderate affinity for the σ2 receptor (Ki = 25.2 nM) .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    σ1|σ2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    155798-08-6
  • Formula Weight
    420.29
  • Molecular Formula
    C19H21IN2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 20 mg/mL 47.59 mM;H2O : < 0.1 mg/mL
  • SMILES
    Ic1ccc(cc1)C(=O)NC3CCN(Cc2ccccc2)CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • γ-caprolactone

    Gamma-Caprolactone also known as 4-ethyl-4-butanolide or 4-hexanolide belongs to the class of organic compounds known as gamma butyrolactones.

  • DYKDDDDK

    DYKDDDDK

  • DRB18

    DRB18 is a highly effective pan-class inhibitor of glucose transporter proteins (GLUT). It significantly modulates energy-related metabolism in A549 cells by inducing alterations in the abundance of metabolites associated with glucose-related pathways.